Abstract
To investigate the involvement of different cytochrome P-450 monooxygenases in fatty acid hydroxylation in frog liver microsomes, the effect of various inhibitors of cytochrome P-450 monooxygenases on the ω- and (ω-1)-hydroxylation of laurate was examined. The ω/ω-1-hydroxylation ratios were changed significantly by various levels of carbon monooxide (CO) inhibition; the formation of ω-hydroxylaurate was more sharply inhibited by various levels of CO than was the formation of (ω-1)-hydroxylaurate. On the contrary, metyrapone inhibited only the formation of (ω-1)-hydroxylaurate and stimulated the formation of ω-hydroxylaurate. 7,8-Benzoflavone as well as CO was more inhibitory to the ω-hydroxylation of laurate. At low concentrations of KCN (0.2 and 0.1 mM), the (ω-1)-hydroxylase activity was stimulated, but both the ω- and (ω-1)-hydroxylase activities were inhibited at the higher concentrations (5–10 mM). The effect of drugs and hydroxylaurate isomers on the ω- and (ω-1)-hydroxylation was also examined. Aminopyrine showed a stimulative effect on ω-hydroxylase activity and no effect on the (ω-1)-hydroxylase activity, whilep-nitroanisole inhibited the (ω-1)-hydroxylase activity and showed almost no effect on the ω-hydroxylase activity. 12-Hydroxylaurate inhibited both the ω- and (ω-1)-hydroxylase activities, but the ω-hydroxylase activity was inhibited to a much greater extent. 11-Hydroxylaurate had no effect on either hydroxylation. These findings strongly support the hypothesis that different cytochrome P-450 species are involved in the hepatic microsomal hydroxylation of laurate at ω- and (ω-1)-positions in the frog.
Similar content being viewed by others
References
Preiss, B., and Bloch, K. (1964) J. Biol. Chem. 239, 85–88.
Kusunose, M., Kusunose, E., and Coon, M.J. (1964) J. Biol. Chem. 239, 1374–1380.
Lu, A.Y.H., and Coon, M.J. (1968) J. Biol. Chem. 243, 1331–1332.
Ichihara, K., Kusunose, E., and Kusunose, M. (1969) Biochim. Biophys. Acta 176, 704–712.
Björkhem, I., and Danielsson, H. (1970) Eur. J. Biochem. 17, 450–459.
Heinz, E., Tulloch, A.P., and Spencer, J.F.T. (1970) Biochim. Biophys. Acta 202, 49–55.
Ellin, A., Jakobsson, S.V., Schenkman, J.B., and Orrenius, S. (1972) Arch. Biochem. Biophys. 150, 64–71.
Okita, R.T., Jakobsson, S.V., Prough, R.A., and Masters, B.S.S. (1979) Biochem. Pharmacol. 28, 3385–3390.
Ichihara, K., Yamakawa, I., Kusunose, E., and Kusunose, M. (1979) J. Biochem. 86:139–146.
Kusunose, E., Ogita, K., Ichihara, K., and Kusunose, M. (1981) J. Biochem. 90, 1069–1076.
Miura, Y., and Fulco, A.J. (1974) J. Biol. Chem. 249, 1880–1888.
Miura, Y., and Fulco, A.J. (1975) Biochim. Biophys. Acta 388, 305–317.
Salaün, J.-P., Benveniste, I., Reichhart, D., and Durst, F. (1978) Eur. J. Biochem. 90, 155–159.
Miura, Y., Hisaki, H., and Ueta, N. (1978) Biochim. Biophys. Acta 531, 149–157.
Miura, Y. (1981) Lipids, 16, 721–725.
Ellin, Å., Orrenius, S., Pilotti, Å., Swahn, C.-G. (1973) Arch. Biochem. Biophys. 158, 597–604.
Moldeus, P., Ellin, Å., Thor, H., and Orrenius, S. (1974)in Regulation of Hepatic Metabolism (Lundquist, F. and Tygstrup, N., eds.) pp. 659–675, Munksgaard, Copenhagen.
Ellin, Å., and Orrenius, S. (1975) FEBS Lett. 50, 378–381.
Kupfer, D., Miranda, G.K., Navarro, J., Piccolo, D.E., and Theoharides, A.D. (1979) J. Biol. Chem. 254, 10405–10414.
Okita, R.T., Prough, R.A. and Masters, B.S.S. (1980) in Microsomes, Drug Oxidations and Chemical Carcinogenesis (Coon, M.J., Conney, A.H., Estabrook, R.W., Gelboin, H.V., Gillette, J.R., and O'Brien, P.J., eds.) Vol. II, pp. 741–744, Academic Press, New York, NY.
Kupfer, D. (1980) Pharmac. Ther. 11, 469–496.
Theoharides, A.D., and Kupfer, D. (1981) J. Biol. Chem. 256, 2168–2175.
Miura, Y., Hisaki, H., and Ueta, N. (1980) Comp. Biochem. Physiol. 67B, 541–547.
Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. (1951) J. Biol. Chem. 193, 265–275.
La Du, B.N., Gaudette, L., Trousof, N., and Brodie, B.B. (1955) J. Biol. Chem. 214, 741–752.
Gillette, J.R., Brodie, B.B., and La Du, B.N. (1957) J. Pharmac. Exp. Ther. 119, 532–540.
Oshino, N., Imai, Y., and Sato, R. (1966) Biochim. Biophys. Acta 128, 13–28.
Matsubara, T., and Tochino, Y. (1976) Arch. Biochem. Biophys. 172, 696–705.
Kamataki, T., Kitada, M., Chiba, K., Kitagawa, H., Imai, Y., and Sato, R. (1980) Biochem. Pharmac. 29, 1141–1147.
Author information
Authors and Affiliations
About this article
Cite this article
Miura, Y. Effect of inhibitors on ω-and (ω-1)-hydroxylation of lauric acid by frog liver microsomes. Lipids 17, 864–869 (1982). https://doi.org/10.1007/BF02534580
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02534580